• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不健康的生活方式和非酒精性脂肪肝与心血管健康结局的关联。

Associations of Unhealthy Lifestyle and Nonalcoholic Fatty Liver Disease With Cardiovascular Healthy Outcomes.

机构信息

Department of Clinical Research The First Affiliated Hospital of Jinan University Guangzhou Guangdong China.

School of Public Health Xi'an Jiaotong University Health Science Center Xi'an Shaanxi China.

出版信息

J Am Heart Assoc. 2023 Dec 5;12(23):e031440. doi: 10.1161/JAHA.123.031440. Epub 2023 Nov 28.

DOI:10.1161/JAHA.123.031440
PMID:38014686
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10727317/
Abstract

BACKGROUND

The role of nonalcoholic fatty liver disease (NAFLD) as a mediator in the association between various unhealthy lifestyles and major adverse cardiovascular events and all-cause death remains unclear.

METHODS AND RESULTS

This study used data from the UK Biobank, with follow-up until the end of 2021. It involved the calculation of unweighted and weighted lifestyle scores using the Cox model to classify participants on the basis of these scores. Additionally, the research assessed the mediation effect proportion of NAFLD using the difference method and examined the interaction and joint effects of lifestyle and NAFLD on health outcomes. Among the 134 616 enrolled participants, 4024 had records of major adverse cardiovascular events, while among the 130 144 participants included in the analysis of all-cause death, 6697 deaths occurred. The proportions of the association between overall lifestyle and major adverse cardiovascular events mediated by NAFLD were 19.4% and 21.7% (95% CI, 16.2-22.6 and 17.8-25.7) for scores 1 and 2, respectively, and those for all-cause death were 14.1% and 10.1% (95% CI, 11.3-17.1 and 7.9-12.2). After fully adjusting for traditional cardiovascular risk factors, the mediating effects declined across both outcomes. The associations between overall lifestyle and outcomes were stronger among those of the non-NAFLD group, and significant interactions were observed between overall lifestyle and NAFLD status. The joint analysis revealed that patients with NAFLD with unhealthy lifestyle had the highest risk of major adverse cardiovascular events and all-cause death.

CONCLUSIONS

Improving lifestyle and addressing metabolic risk factors are essential for cardiovascular risk management in patients with NAFLD.

摘要

背景

非酒精性脂肪性肝病(NAFLD)作为各种不健康生活方式与主要不良心血管事件和全因死亡之间关联的中介因素的作用尚不清楚。

方法和结果

本研究使用了英国生物库的数据,随访至 2021 年底。研究使用 Cox 模型计算未经加权和加权的生活方式评分,根据这些评分对参与者进行分类。此外,研究还使用差异法评估了 NAFLD 的中介效应比例,并检验了生活方式和 NAFLD 对健康结果的交互和联合效应。在纳入的 134616 名参与者中,有 4024 人有主要不良心血管事件的记录,而在纳入全因死亡分析的 130144 名参与者中,有 6697 人死亡。NAFLD 介导的整体生活方式与主要不良心血管事件之间的关联比例,评分 1 和 2 分别为 19.4%和 21.7%(95%CI,16.2-22.6 和 17.8-25.7),全因死亡的比例分别为 14.1%和 10.1%(95%CI,11.3-17.1 和 7.9-12.2)。在充分调整传统心血管危险因素后,两种结局的中介效应均下降。在非 NAFLD 组中,整体生活方式与结局之间的关联更强,并且观察到整体生活方式与 NAFLD 状态之间存在显著的交互作用。联合分析显示,患有 NAFLD 且生活方式不健康的患者发生主要不良心血管事件和全因死亡的风险最高。

结论

改善生活方式和解决代谢危险因素对 NAFLD 患者的心血管风险管理至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af74/10727317/d3c136bed95e/JAH3-12-e031440-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af74/10727317/243731ab1ca8/JAH3-12-e031440-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af74/10727317/e9d8f563e6d2/JAH3-12-e031440-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af74/10727317/d3c136bed95e/JAH3-12-e031440-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af74/10727317/243731ab1ca8/JAH3-12-e031440-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af74/10727317/e9d8f563e6d2/JAH3-12-e031440-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af74/10727317/d3c136bed95e/JAH3-12-e031440-g002.jpg

相似文献

1
Associations of Unhealthy Lifestyle and Nonalcoholic Fatty Liver Disease With Cardiovascular Healthy Outcomes.不健康的生活方式和非酒精性脂肪肝与心血管健康结局的关联。
J Am Heart Assoc. 2023 Dec 5;12(23):e031440. doi: 10.1161/JAHA.123.031440. Epub 2023 Nov 28.
2
A healthy lifestyle, Life's Essential 8 scores and new-onset severe NAFLD: A prospective analysis in UK Biobank.健康的生活方式、“生命必需的 8 项指标”评分与新发严重非酒精性脂肪性肝病:英国生物库的前瞻性分析。
Metabolism. 2023 Sep;146:155643. doi: 10.1016/j.metabol.2023.155643. Epub 2023 Jun 26.
3
Association between Lifestyle Modification and All-Cause, Cardiovascular, and Premature Mortality in Individuals with Non-Alcoholic Fatty Liver Disease.生活方式改变与非酒精性脂肪性肝病患者全因、心血管和过早死亡的关系。
Nutrients. 2024 Jun 28;16(13):2063. doi: 10.3390/nu16132063.
4
Healthy Lifestyle Is Associated with Reduced Mortality in Patients with Non-Alcoholic Fatty Liver Disease.健康的生活方式与非酒精性脂肪性肝病患者的死亡率降低有关。
Nutrients. 2022 Sep 14;14(18):3785. doi: 10.3390/nu14183785.
5
Machine Learning Approach to Classify Cardiovascular Disease in Patients With Nonalcoholic Fatty Liver Disease in the UK Biobank Cohort.基于英国生物库队列的机器学习方法对非酒精性脂肪性肝病患者心血管疾病的分类。
J Am Heart Assoc. 2022 Jan 4;11(1):e022576. doi: 10.1161/JAHA.121.022576. Epub 2021 Dec 20.
6
Increased Risk for Cardiovascular Events in Patients with Diabetic Kidney Disease and Non-Alcoholic Fatty Liver Disease.患有糖尿病肾病和非酒精性脂肪性肝病的患者发生心血管事件的风险增加。
Nephron. 2019;141(1):24-30. doi: 10.1159/000493472. Epub 2018 Nov 1.
7
Nonalcoholic fatty liver disease as a potential risk factor of cardiovascular disease.非酒精性脂肪性肝病作为心血管疾病的潜在危险因素。
Eur J Gastroenterol Hepatol. 2015 Mar;27(3):193-9. doi: 10.1097/MEG.0000000000000254.
8
Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association.非酒精性脂肪性肝病与心血管风险:美国心脏协会的科学声明
Arterioscler Thromb Vasc Biol. 2022 Jun;42(6):e168-e185. doi: 10.1161/ATV.0000000000000153. Epub 2022 Apr 14.
9
Nonalcoholic Fatty Liver Disease (NAFLD)-A New Cardiovascular Risk Factor in Peritoneal Dialysis Patients.非酒精性脂肪性肝病(NAFLD)——腹膜透析患者的一种新的心血管危险因素。
Perit Dial Int. 2016 Jul-Aug;36(4):427-32. doi: 10.3747/pdi.2014.00223. Epub 2015 Oct 16.
10
Cardiovascular Risk in Children with Nonalcoholic Fatty Liver Disease (NAFLD).非酒精性脂肪性肝病(NAFLD)患儿的心血管风险
Curr Pediatr Rev. 2020;16(4):294-297. doi: 10.2174/1573396316666201009154913.

引用本文的文献

1
Peripheral blood mitochondrial DNA copy number as a predictor of steatotic liver disease development: insights from epidemiological and experimental studies.外周血线粒体DNA拷贝数作为脂肪性肝病发生的预测指标:来自流行病学和实验研究的见解
Environ Health Prev Med. 2025;30:42. doi: 10.1265/ehpm.25-00025.
2
Consumption of Ultra-Processed Food and Risk of Non-Alcoholic Fatty Liver Disease: A Prospective Analysis of the Korean Genome and Epidemiology Study.超加工食品的消费与非酒精性脂肪性肝病风险:韩国基因组与流行病学研究的前瞻性分析
Mol Nutr Food Res. 2025 Jul;69(13):e70099. doi: 10.1002/mnfr.70099. Epub 2025 May 9.
3

本文引用的文献

1
Social isolation, loneliness, and incident type 2 diabetes mellitus: results from two large prospective cohorts in Europe and East Asia and Mendelian randomization.社会隔离、孤独感与2型糖尿病发病:来自欧洲和东亚两个大型前瞻性队列及孟德尔随机化研究的结果
EClinicalMedicine. 2023 Sep 21;64:102236. doi: 10.1016/j.eclinm.2023.102236. eCollection 2023 Oct.
2
Types of Physical Activity in Nonalcoholic Fatty Liver Disease and All-Cause and Cardiovascular Mortality.非酒精性脂肪性肝病中的体育活动类型与全因死亡率和心血管死亡率
J Clin Med. 2023 Feb 28;12(5):1923. doi: 10.3390/jcm12051923.
3
Comparison between obese and non-obese nonalcoholic fatty liver disease.
Comorbidity patterns and implications for disease control: a network analysis of medical records from Shanghai, China.
共病模式及其对疾病控制的影响:来自中国上海的病历网络分析
Front Public Health. 2025 Mar 10;13:1516215. doi: 10.3389/fpubh.2025.1516215. eCollection 2025.
肥胖与非肥胖非酒精性脂肪性肝病的比较。
Clin Mol Hepatol. 2023 Feb;29(Suppl):S58-S67. doi: 10.3350/cmh.2022.0350. Epub 2022 Dec 5.
4
Mediation analysis of leisure activities on the association between cognitive function and mortality: a longitudinal study of 42,942 Chinese adults 65 years and older.休闲活动对认知功能与死亡率之间关联的中介分析:一项对42942名65岁及以上中国成年人的纵向研究。
Epidemiol Health. 2022;44:e2022112. doi: 10.4178/epih.e2022112. Epub 2022 Nov 27.
5
Healthy Lifestyle Is Associated with Reduced Mortality in Patients with Non-Alcoholic Fatty Liver Disease.健康的生活方式与非酒精性脂肪性肝病患者的死亡率降低有关。
Nutrients. 2022 Sep 14;14(18):3785. doi: 10.3390/nu14183785.
6
Life's Essential 8: Updating and Enhancing the American Heart Association's Construct of Cardiovascular Health: A Presidential Advisory From the American Heart Association.《生命的基础 8:更新和强化美国心脏协会心血管健康构建:美国心脏协会主席特别咨询报告》。
Circulation. 2022 Aug 2;146(5):e18-e43. doi: 10.1161/CIR.0000000000001078. Epub 2022 Jun 29.
7
Association of Lifestyle Factors and Antihypertensive Medication Use With Risk of All-Cause and Cause-Specific Mortality Among Adults With Hypertension in China.中国高血压患者生活方式因素及降压药物治疗与全因及特定原因死亡率的相关性研究。
JAMA Netw Open. 2022 Feb 1;5(2):e2146118. doi: 10.1001/jamanetworkopen.2021.46118.
8
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice.2021年欧洲心脏病学会临床实践中心血管疾病预防指南。
Eur Heart J. 2021 Sep 7;42(34):3227-3337. doi: 10.1093/eurheartj/ehab484.
9
Data mining in clinical big data: the frequently used databases, steps, and methodological models.临床大数据中的数据挖掘:常用数据库、步骤和方法学模型。
Mil Med Res. 2021 Aug 11;8(1):44. doi: 10.1186/s40779-021-00338-z.
10
Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States.代谢相关脂肪性肝病与全因死亡率增加相关在美国。
J Hepatol. 2021 Dec;75(6):1284-1291. doi: 10.1016/j.jhep.2021.07.035. Epub 2021 Aug 8.